243 related articles for article (PubMed ID: 19265119)
1. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
2. Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.
Sarcon AK; Desierto MJ; Zhou W; Visconte V; Gibellini F; Chen J; Young NS
Exp Hematol; 2009 Apr; 37(4):477-86. PubMed ID: 19216020
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity in mice bearing lprcg: a novel mutant gene.
Kimura M; Matsuzawa A
Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
[TBL] [Abstract][Full Text] [Related]
5. Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.
Matsuzawa A; Shimizu M; Takeda Y; Nagase H; Sayama K; Kimura M
Immunology; 2002 Aug; 106(4):470-5. PubMed ID: 12153509
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
Fecho K; Bentley SA; Cohen PL
Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
[TBL] [Abstract][Full Text] [Related]
7. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
Fecho K; Cohen PL
J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Weintraub JP; Eisenberg RA; Cohen PL
J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Watanabe D; Suda T; Hashimoto H; Nagata S
EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions in the lpr and gld models of systemic autoimmunity.
Sobel ES
Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
[TBL] [Abstract][Full Text] [Related]
13. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the Fas pathway impairs CD8+ T cell memory.
Dudani R; Russell M; van Faassen H; Krishnan L; Sad S
J Immunol; 2008 Mar; 180(5):2933-41. PubMed ID: 18292515
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.
Chen J; Feng X; Desierto MJ; Keyvanfar K; Young NS
Blood; 2015 Dec; 126(24):2621-31. PubMed ID: 26491068
[TBL] [Abstract][Full Text] [Related]
16. Genotype-restricted lymphoproliferation in autoimmune lpr mice.
Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T
Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659
[TBL] [Abstract][Full Text] [Related]
17. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Mittelstadt PR; Ashwell JD
J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
[TBL] [Abstract][Full Text] [Related]
18. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
19. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
[TBL] [Abstract][Full Text] [Related]
20. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
